| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.07 |